Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Receivables: 2018-2019

Historic Receivables for DiaMedica Therapeutics (DMAC) over the last 1 years, with Sep 2019 value amounting to $1.3 million.

  • DiaMedica Therapeutics' Receivables was N/A to $1.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $6.5 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2018, which is N/A change from last year.
  • According to the latest figures from Q3 2019, DiaMedica Therapeutics' Receivables is $1.3 million, which was down 40.77% from $2.1 million recorded in Q2 2019.
  • DiaMedica Therapeutics' Receivables' 5-year high stood at $2.1 million during Q2 2019, with a 5-year trough of $1.3 million in Q3 2019.
  • For the 2-year period, DiaMedica Therapeutics' Receivables averaged around $1.6 million, with its median value being $1.6 million (2018).